• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

What happened in optometry this week: March 18 - March 22


Catch up on what happened in optometry during the week of March 18-March 22.

Catch up with what Optometry Times shared this week:

OKYO Pharma announces additional statistically significant findings in results from Phase 2 trial of OK-101 (0.05%)

By Jordana Joy, Associate Editor

OKYO Pharma, a clinical-stage biopharmaceutical company, announced additional key findings from clinical data set analyses from its Phase 2 clinical trial evaluating the safety and efficacy of OK-101 (0.05%), an ophthalmic solution in patients with dry eye disease (DED), according to a news release.

Read here...

What you missed at Vision Expo East 2024

By Jordana Joy, Associate Editor

With Vision Expo East 2024 wrapping up its last year in New York City, the conference had plenty of the latest innovations in technology, treatment, glasses frames, and fashion on display.

Read here...

Myopia: An epidemic of global proportions

By Erin Tomiyama, OD, PhD, FAAO

Many current articles on myopia contain a citation to the 2016 study by Holden et al, which discusses the increasing prevalence of myopia worldwide.1 At the time of the study, approximately 23% of the world’s population had myopia, with a predicted increase to 50% by the year 2050. The highest prevalence rates were found in Asia-Pacific countries, with East Asia, Southeast Asia, and North America not far behind.1

Read here...

Faster epithelial healing for patients with corneal abrasion and PRK

By Leela V. Raju, MD

The recovery processes are similar for patients who present with a large corneal abrasion or undergo photorefractive keratectomy (PRK; laser ablation to remodel the corneal stroma). The wound is often very painful until the corneal epithelium has healed, which can take up to a week. Our goals are to control pain, prevent infection, and achieve epithelial healing as rapidly as possible, in turn further reducing infection risk and pain.

Listen here...

Going global: Improving vision care for Latino and Hispanic patients

By Diana Canto-Sims, OD

March 23, 2024, is designated as World Optometry Day. This presents an opportunity to appreciate expectations for and hurdles related to serving the rapidly-growing Hispanic and Latino populations in the United States.

Read here...

Related Videos
Charles Leclercq, CEO of ARxVision, details the new ARx AI headset and its uses
© 2024 MJH Life Sciences

All rights reserved.